158 related articles for article (PubMed ID: 35985475)
1. CK1α upregulates the IFNAR1 expression to prompt the anti-HBV effect of type I IFN in hepatoma carcinoma cells.
Xiong J; Jiang Y; Zhang J; Chen Y; Hu Y
Virol Sin; 2022 Dec; 37(6):894-903. PubMed ID: 35985475
[TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
Chen J; Xu W; Chen Y; Xie X; Zhang Y; Ma C; Yang Q; Han Y; Zhu C; Xiong Y; Wu K; Liu F; Liu Y; Wu J
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122987
[TBL] [Abstract][Full Text] [Related]
3. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
[TBL] [Abstract][Full Text] [Related]
4. Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling.
Liu J; Carvalho LP; Bhattacharya S; Carbone CJ; Kumar KG; Leu NA; Yau PM; Donald RG; Weiss MJ; Baker DP; McLaughlin KJ; Scott P; Fuchs SY
Mol Cell Biol; 2009 Dec; 29(24):6401-12. PubMed ID: 19805514
[TBL] [Abstract][Full Text] [Related]
5. Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1.
Xia C; Vijayan M; Pritzl CJ; Fuchs SY; McDermott AB; Hahm B
J Virol; 2015 Dec; 90(5):2403-17. PubMed ID: 26676772
[TBL] [Abstract][Full Text] [Related]
6. Silencing SIRT1 promotes the anti-HBV action of IFN-α by regulating Pol expression and activating the JAK-STAT signaling pathway.
Tang Q; Meng C; Liu Y; Cheng Y; Liu Y; Long Y; Sun S; Feng F
Int Immunopharmacol; 2023 Nov; 124(Pt B):110939. PubMed ID: 37741128
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells.
Zhang J; Liu K; Zhang G; Ling N; Chen M
Virol J; 2022 Feb; 19(1):28. PubMed ID: 35144643
[TBL] [Abstract][Full Text] [Related]
8. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus hijacks CTHRC1 to evade host immunity and maintain replication.
Bai L; Zhang W; Tan L; Yang H; Ge M; Zhu C; Zhang R; Cao Y; Chen J; Luo Z; Ho W; Liu F; Wu K; Wu J
J Mol Cell Biol; 2015 Dec; 7(6):543-56. PubMed ID: 26180054
[TBL] [Abstract][Full Text] [Related]
10. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
11. The down-regulation of casein kinase 1 alpha as a host defense response against infectious bursal disease virus infection.
Zhang L; Li H; Chen Y; Gao X; Lu Z; Gao L; Wang Y; Gao Y; Gao H; Liu C; Cui H; Zhang Y; Pan Q; Qi X; Wang X
Virology; 2017 Dec; 512():211-221. PubMed ID: 28988058
[TBL] [Abstract][Full Text] [Related]
12. Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.
Katlinskaya YV; Katlinski KV; Lasri A; Li N; Beiting DP; Durham AC; Yang T; Pikarsky E; Lengner CJ; Johnson FB; Ben-Neriah Y; Fuchs SY
Mol Cell Biol; 2016 Jan; 36(7):1124-35. PubMed ID: 26811327
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
[TBL] [Abstract][Full Text] [Related]
14. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
15. Desmethoxycurcumin aids IFNα's anti-HBV activity by antagonising CRYAB reduction and stabilising IFNAR1 protein.
Wei J; Deng X; Dai W; Xie L; Zhang G; Fan X; Li X; Jin Z; Xiao Q; Chen T
J Drug Target; 2023 Dec; 31(9):976-985. PubMed ID: 37851377
[TBL] [Abstract][Full Text] [Related]
16. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
[TBL] [Abstract][Full Text] [Related]
17. The anti-HBV effect mediated by a novel recombinant eukaryotic expression vector for IFN-α.
Yu H; Hou Z; Han Q; Zhang C; Zhang J
Virol J; 2013 Aug; 10():270. PubMed ID: 23984795
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor.
Cho IR; Oh M; Koh SS; Malilas W; Srisuttee R; Jhun BH; Pellegrini S; Fuchs SY; Chung YH
Int J Mol Med; 2012 Apr; 29(4):581-6. PubMed ID: 22218495
[TBL] [Abstract][Full Text] [Related]
19. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells.
Caselmann WH; Meyer M; Scholz S; Hofschneider PH; Koshy R
J Infect Dis; 1992 Nov; 166(5):966-71. PubMed ID: 1328410
[TBL] [Abstract][Full Text] [Related]
20. Ligand-stimulated downregulation of the alpha interferon receptor: role of protein kinase D2.
Zheng H; Qian J; Varghese B; Baker DP; Fuchs S
Mol Cell Biol; 2011 Feb; 31(4):710-20. PubMed ID: 21173164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
